About Dr. Vijay KR Rao

He is a highly qualified and experienced Rheumatologist based in Bangalore, holding degrees including MBBS, MRCP (UK) in General Medicine, and MRCP (UK) in Rheumatology. With a wealth of contributions to academia and research, he serves as a Consultant Rheumatologist and Clinical Director at Divisha Arthritis and Medical Center, demonstrating a commitment to advancing rheumatological knowledge and providing dedicated patient care.

Dr. Vijay KR Rao

Education Qualification

  • MBBS, 2002
  • MRCP (London), 2009
  • MRCP Rheumatology (London), 2012
  • CCT in Rheumatology (UK), 2013
  • FRCP (Edinburgh, 2016)

Other Qualification

  • United States Medical Licensing Exam Educational Commission for Foreign Medical Graduates Certification, 2005

Membership of Professional Bodies

  • British Society of Rheumatology
  • General Medical Council
  • Royal College of Physicians
  • Indian Rheumatology Association
  • Indian Medical Association
  • Association of Physicians of India
  • Karnataka Medical Council 
  • Executive Council Member,
  • Karnataka Rheumatology Association

Academics & Publications

Academics

  1. External teaching faculty DNB Rheumatology Program Manipal Hospital Bangalore 
  2. MRCP examiner for India, MRCP PACE Sexam centre, Manipal Hospital Bangalore 
  3. Past Assistant Editor, Indian Journal of Rheumatology
  4. Regular Invited Speaker at National, Regional and City Rheumatology meetings 
  5. Convenor of Rheumatology academic meetings Karnataka Rheumatology  Association 

Publications

  • Incidence of Sacroiliitis among Patients Presenting with Chronic Low Back Pain to a Tertiary Care Spine Center. J Orth Joint Surg 2023;5(2):56-58
  • Tofacitinib in pyoderma gangrenosum – A case series. IntJ Rheum Dis. 2023;00:1-4. doi:10.1111/1756-185X.14810
  • Uncommon presentation of granulomatosis with polyangiitis: Prostate involvement. Int J Rheum Dis. 2023;00:1-4. doi:10.1111/1756-185X.14831
  • Tofacitinib as monotherapy in cutaneous polyarteritis nodosa: a case series, Rheumatology Advances in Practice, 2023; rkad049, https://doi.Org/10.1093/rap/rkad049
  • Risk factors associated with COVID-19 in systemic lupus erythematosus: Results from a longitudinal prospective cohort. Lupus. 2023;32(4):560-564. doi:10.1177/09612033231155837
  • Impaired Mobility Drives Disability in Psoriatic Arthritis – An Observational Study from Karnataka Psoriatic Arthritis Cohort (KPsAC). Indian Journal of Rheumatology 18(2):p 120-125, June 2023. | DOI: 10.4103/injr.injr_285_21
  • Clinical profiling of psoriatic arthritis: an observational cross-sectional study from Karnataka Psoriatic Arthritis Cohort. Indian J Rheumatol 2022;17:340-6
  • Comorbidity burden in psoriatic arthritis and its impact on disease measures. Indian J Rheumatol 0; 0:0
  • Herpes zoster reactivation after COVID-19 vaccination in patients with autoimmune diseases. Indian J Rheumatol 2022; 17:216-21
  • Post corona virus Disease-19 (COVID-19): Hyper inflammatory syndrome-associated bilateral anterior uveitis and multifocal serous retinopathy secondary to steroids. Indian J Rheumatol 2021; 16:451 -5
  • Do all patients with rheumatic diseases have a higher risk of COVID 19? Initial results from the Karnataka Rheumatology Association COVID 19 Cohort Study (KRACC). Indian J Rheumatol 2021;16:164-8.
  • Real-life Tolerability and Effectiveness of Adalimumab Biosimilar in Ankylosing Spondylitis: The Adalimumab Biosimilar Patient Registry Data. ACR Open Rheumatology, 1: 480-484. https://d0i.0rg/l 0.1002/acr2.11067
  • Incidence of infection other than tuberculosis in patients with autoimmune rheumatic diseases treated with bDMARDs: a real- time clinical experience from India. Rheumatology International https://d0i.0rg/l 0.1007/s00296-019-04245-4.
  • Biologies and risk of tuberculosis in autoimmune rheumatic diseases: A real-world clinical experience from India. Int J Rheum Dis. 2018;00:1 -8. https://d0i.0rg/l 0.1111/ 1756-185X.13376
  • Maternal and fetal outcomes of lupus pregnancies: A collective effort by Karnataka Rheumatologists. Lupus. 2020 Aug 2:961203320944503.doi:10.1177/0961203320944503
  • Fertility and pregnancy in systemic sclerosis and other autoimmune rheumatic diseases. Indian J Rheumatol 2016;11:150-5.
  • Hydroxychloroquine-related retinal toxicity. Rheumatology (Oxford). 2016 Jun;55(6):957-67. doi: 10.1093/rheumatology/kev357. Epub 2015 Oct
  • Evaluation of epratuzumab as a biologic therapy in lupus. Immunotherapy. Immunotherapy. 2014 Nov;6(11 ):1165-75. doi: 10.2217/imt.l4.80
  • Advances in the assessment of lupus disease activity and damage. Curr Opin Rheumatol 2014, 26:510-519.
  • To what extent are we following NICE guidance on the switching of biological drugs in rheumatoid arthritis? A regional audit of practice in the midlands. BMC Musculoskeletal Disord. 2014 Sep 2; 15(1 ):290. doi: 10.1186/1471 -2474-15-290
  • Sjogren’s syndrome. Other Autoimmune Rheumatic Disorders. Medicine. Mar 2014; 42 (3): 162- 166. http://dx.doi.Org/10.1016/j.mpmed.2013.12.002.
  • Latest advances in connective tissue disorders. Ther Adv Musculoskeletal Pis. 2013 Aug; 5(4): 234-49. doi: 10.1177/1759720X13480280 

Abstract

  • CORRELATION OF ABNORMAL DIET AND ABNORMAL LIFESTYLE WITH INFLAMMATORY MARKERS AND RAPID 3 SCORE IN AUTOIMMUNE RHEUMATIC DISEASE-RELATED ARTHRITIS (RA, SPA AND PSA) AFTER TREATMENT; S. S, A. R. K, R. Patel, V. As, V. Kr Rao; DOI: 10.1136/annrheumdis-2023-eular.5501
  • Undiagnosed depression in psoriatic arthritis, Indian Journal of Rheumatology, Supplement 1 2022    Volume        171 Issue        5      (Supplement) Page Nos.1-278, DOI:10.4103/0973-3698.362016.
  • Undiagnosed anxiety in psoriatic arthritis, Indian Journal of Rheumatology, Supplement 1 2022 Volume  171 Issue 5      (Supplement) Page Nos. 1-278, DOI:10.4103/0973-3698.362016.
  • Use of RAPID3 in psoriatic arthritis, Indian Journal of Rheumatology, Supplement 1 2022 Volume 171 Issue 5 (Supplement) Page Nos. 1-278, DOI:10.4103/0973-3698.362016.
  • Clinical experience of tofacitinib in rheumatoid arthritis over 24 weeks: Real-world data from two centres in South India; Oral Presentation. Indian Journal of Rheumatology 13(Suppl 2): p S79-S92, December 2018. | DOI: 10.4103/0973-3698.247335
  • Podocytic Abnormalities in SLE – Parallel mechanism affecting the kidney, DOI: 10.1136/annrheumdis-2015-eular.4313 (EULAR 2015 abstract publication).
  • Evaluation of Rheumatology Admissions in a Teaching Hospital: A Trainee’s Perspective, Ann Rheum Dis 2012; 71 (Suppl3): 309.
  • Andersson’s lesion or infective discitis? – A diagnostic dilemma, Indian Journal of Rheumatology, Volume 6, Issue 3, Supplement, November 2011, Pages S6-S7, ISSN 0973-3698,10.1016/S0973-3698 (11) 60115-5.
  • The role of musculoskeletal ultrasound in the management of peripheral arthritis in a Rheumatology outpatient clinic, Indian Journal of Rheumatology, Volume 6, Issue 3, Supplement, November 2011, Page S7, ISSN 0973-3698,10.1016/S0973-3698 (11) 60118-0.
  • Evaluation of Inpatient Referrals to the Rheumatology service in a teaching Hospital: a Trainee’s perspective, Rheumatology, Rheumatology (2011) 50 (suppl 3): iii55-iii59.
  • Sudden onset of Confluent Lumbosacral Plexopathy and severe Haemolytic Anaemia in Patient with longstanding mild SLE, Rheumatology (2010) 49 (suppl 1): i35-i43.
Divisha logo

Contact Us

For inquiries or appointments, feel free to reach out to Divisha Clinic. Our dedicated team, led by Dr. Vijay KR Rao, is ready to assist you with any questions or healthcare needs, ensuring a seamless and responsive connection for your well-being.

divisha.center@gmail.com

9916770444

Divisha Arthritis and Medical Center
500/A, 1st G cross, 8th Main, 4th block 3rd stage, Basaveshwarnagar , Bangalore 560079

Mon-Sat: 09 am-06 pm, Sunday: Closed